The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 179.00
Bid: 178.50
Ask: 187.50
Change: 1.00 (0.56%)
Spread: 9.00 (5.042%)
Open: 187.50
High: 187.50
Low: 178.50
Prev. Close: 178.00
NXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Apr 2023 07:00

RNS Number : 0267W
Norcros PLC
13 April 2023
 

 

13 April 2023 

Trading update

Norcros plc ("Norcros" or the "Group"), a market leading supplier of high quality and innovative bathroom and kitchen products, will announce its Preliminary Results for the year ended 31 March 20231 on 15 June 2023. In advance of this, the Group is providing the following trading update.

 

Full year trading performance - Underlying operating profit up 10% and in line with market expectations2

 

The Group has continued to demonstrate resilience in its business model, trading well against the challenging macroeconomic backdrop and the Board expects underlying operating profit for the year to 31 March 20231 to be at a record level and in line with market expectations2.

 

Group revenue for the year ended 31 March 20231 is expected to be approximately £440 million (2022: £396.3 million), 11.3% above prior year on a reported basis and 1.5% above on a constant currency "CC3" and like for like4 "LFL" basis.

 

Revenue increase on prior year

Reported

LFL4

FY

H1

H2

FY

UK

15.2%

(3.4%)

3.3%

(0.2%)

South Africa

3.9%

10.0%

(2.2%)

3.9%

South Africa at CC3

4.6%

9.7%

(0.6%)

4.6%

Group

11.3%

1.2%

1.3%

1.3%

Group at CC3

11.5%

1.1%

1.9%

1.5%

 

Our UK business has continued to perform well, with revenue at 15.2% above prior year on a reported basis and broadly in line with prior year on a LFL4 basis. Our performance demonstrated the breadth of our distribution channels, strong stock management and excellent levels of service resulting in market share gains.

 

Our South African business continued to perform robustly, despite market conditions being more challenging in the second half of the year, gaining share as a result of our market leading positions and stock availability. Reported revenue for the year was 3.9% higher than prior year and 4.6% higher than prior year on a constant currency basis.

 

Financial position and extension of banking facilities

The Group remains in a strong financial position with net debt (on a pre-IFRS 16 basis) at 31 March 20231 expected to be circa £50 million (2022: net cash of £8.6 million). The year on year movement principally reflects the acquisition of Grant Westfield.

 

The Group has extended its £130 million multicurrency revolving credit facility ("RCF") for a further year. The facility has a three year and seven month term to October 2026, with a further year extension available. It also includes the option for an uncommitted accordion facility of £70 million.

 

Norcros Adhesives - closure

It is with regret we have commenced the closure of Norcros Adhesives, a small but loss making division with the loss of 70 jobs. Norcros Adhesives represented approximately 3% of Group revenue in the year. The revenues and approximately £3 million of underlying operating losses are included in the underlying financial results for the year. In addition, costs relating to the closure of circa £5 million (of which circa £2 million represents the gross cash cost) will be separately reported as an exceptional item in the results to 31 March 20231. This represents a cash payback period of less than one year. The net impact on cash is not expected to be significant.

 

Notice of results

The Group will announce its full year results for the year ended 31 March 20231 on Thursday 15 June 2023.

 

Thomas Willcocks, Chief Executive Officer, said:

 

"Norcros has delivered record results, again demonstrating resilience and market share growth, notwithstanding the significant macroeconomic challenges. Whilst market conditions are likely to remain uncertain in the short term, the Board believes that the Group's proven business model, leading customer service proposition, leading brands and highly experienced management teams will continue to deliver market share growth in the year ahead.

 

Whilst I have been with the Group since 2006, and a member of the Executive team at Norcros since August 2021, I was delighted to join the Board from 1 April 2023 as CEO. I would like to take this opportunity, on behalf of myself and the Board, to thank Nick Kelsall for his outstanding commitment to the Group over the last thirty years. He has left the Group in an excellent position to continue growing market share in what remain fragmented and attractive markets. We wish him a long and healthy retirement."

 

1. The accounting reference 'year to 31 March 2023' relates to the 52-week accounting period commencing on 4 April 2022 and ending 2 April 2023

2. Norcros compiled market consensus for the year to 31 March 2023 underlying operating profit is £45.9 million

3. CC refers to constant currency basis

4. LFL excludes Grant Westfield, which was acquired on 31 May 2022

 

 

 

 

 

Enquiries

Norcros plc

Tel: 01625 547700

Thomas Willcocks, Chief Executive Officer

James Eyre, Chief Financial Officer

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

Sophie Miles

Notes to Editors

Norcros is a market leading supplier of high quality and innovative bathroom and kitchen products with operations primarily in the UK and South Africa.

 

· Based in the UK, Norcros operates under seven brands:

· Triton - Market leader in the manufacture and marketing of showers in the UK

· Merlyn - The UK and Ireland's No.1 supplier of shower enclosures and trays to the residential, commercial and hospitality sectors

· Multipanel - Grant Westfield is a leading manufacturer of high-end waterproof bathroom wall panels

· Vado - A leading manufacturer and supplier of taps, mixer showers, bathroom accessories and valves

· Croydex - A market-leading, innovative designer, manufacturer and distributor of high quality bathroom furnishings and accessories

· Abode - A leading niche designer and distributor of high quality kitchen taps, bathroom taps, and kitchen sinks

· Johnson Tiles - The leading manufacturer and supplier of ceramic tiles in the UK

 

· Based in South Africa, Norcros operates under four brands:

· Tile Africa - Chain of retail stores focused on ceramic and porcelain tiles, and associated products such as sanitaryware, showers and adhesives

· Johnson Tiles South Africa - Manufacturer of ceramic and porcelain tiles

· TAL - The leading manufacturer of ceramic and building adhesives

· House of Plumbing - Market leading supplier of specialist plumbing materials

 

· Norcros is headquartered in Wilmslow, Cheshire and employs around 2,300 people. The Company is listed on the London Stock Exchange. For further information please visit the Company website: http://www.norcros.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQLLFFXZLFBBX
Date   Source Headline
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results
1st Nov 202212:07 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
30th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20227:00 amRNSVoting Rights and Share Capital Update
13th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20229:39 amRNSVoting Rights and Share Capital Update
26th Jul 202212:30 pmRNSHolding(s) in Company
25th Jul 20222:23 pmRNSDirectors' Dealings
19th Jul 20222:05 pmRNSResults of AGM
19th Jul 20221:57 pmRNSDirector Dealings
19th Jul 20227:00 amRNSAGM Trading Statement
15th Jul 20225:08 pmRNSVoting Rights and Share Capital Update
30th Jun 20229:08 amRNSVoting Rights and Share Capital Update
21st Jun 20225:21 pmRNSDirector Declaration
16th Jun 202211:16 amRNSNotice of AGM Annual Report Announcement
14th Jun 20222:25 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.